Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 76

1.

Author response: 25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Ascherio A, Soilu-Hänninen M, Surcel HM, Åivo J.

Neurology. 2018 Apr 3;90(14):668-669. doi: 10.1212/WNL.0000000000005245. No abstract available.

PMID:
29610235
2.

Sun exposure over the life course and associations with multiple sclerosis.

Tremlett H, Zhu F, Ascherio A, Munger KL.

Neurology. 2018 Apr 3;90(14):e1191-e1199. doi: 10.1212/WNL.0000000000005257. Epub 2018 Mar 7.

PMID:
29514944
3.

Reply to "Stratified analyses are necessary to verify the influence of salt intake in multiple sclerosis".

Fitzgerald KC, Munger KL, Ascherio A.

Ann Neurol. 2017 Oct;82(4):649. doi: 10.1002/ana.25055. Epub 2017 Oct 10. No abstract available.

PMID:
28961335
4.

Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses.

Palacios N, Munger KL, Fitzgerald KC, Hart JE, Chitnis T, Ascherio A, Laden F.

Environ Int. 2017 Dec;109:64-72. doi: 10.1016/j.envint.2017.07.013. Epub 2017 Sep 20.

PMID:
28938101
5.

25-Hydroxyvitamin D deficiency and risk of MS among women in the Finnish Maternity Cohort.

Munger KL, Hongell K, Åivo J, Soilu-Hänninen M, Surcel HM, Ascherio A.

Neurology. 2017 Oct 10;89(15):1578-1583. doi: 10.1212/WNL.0000000000004489. Epub 2017 Sep 13.

6.

No association between dietary sodium intake and the risk of multiple sclerosis.

Cortese M, Yuan C, Chitnis T, Ascherio A, Munger KL.

Neurology. 2017 Sep 26;89(13):1322-1329. doi: 10.1212/WNL.0000000000004417. Epub 2017 Aug 25.

7.

Author response: Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Stenager E, Ascherio A.

Neurology. 2017 Jul 25;89(4):411. doi: 10.1212/WNL.0000000000004140. No abstract available.

PMID:
28739666
8.

Sodium intake and multiple sclerosis activity and progression in BENEFIT.

Fitzgerald KC, Munger KL, Hartung HP, Freedman MS, Montalbán X, Edan G, Wicklein EM, Radue EW, Kappos L, Pohl C, Ascherio A; BENEFIT Study Group.

Ann Neurol. 2017 Jul;82(1):20-29. doi: 10.1002/ana.24965.

9.

Polyunsaturated fatty acids and the risk of multiple sclerosis.

Bjørnevik K, Chitnis T, Ascherio A, Munger KL.

Mult Scler. 2017 Dec;23(14):1830-1838. doi: 10.1177/1352458517691150. Epub 2017 Feb 3.

PMID:
28156186
10.

Neonatal vitamin D status and risk of multiple sclerosis: A population-based case-control study.

Nielsen NM, Munger KL, Koch-Henriksen N, Hougaard DM, Magyari M, Jørgensen KT, Lundqvist M, Simonsen J, Jess T, Cohen A, Stenager E, Ascherio A.

Neurology. 2017 Jan 3;88(1):44-51. doi: 10.1212/WNL.0000000000003454. Epub 2016 Nov 30.

11.

Physical activity and the incidence of multiple sclerosis.

Dorans KS, Massa J, Chitnis T, Ascherio A, Munger KL.

Neurology. 2016 Oct 25;87(17):1770-1776. Epub 2016 Sep 28.

12.

People with MS should consume a low-salt diet - NO.

Ascherio A, Munger KL.

Mult Scler. 2016 Dec;22(14):1779-1781. Epub 2016 Sep 8. No abstract available.

PMID:
27609133
13.

Hormone therapy use and physical quality of life in postmenopausal women with multiple sclerosis.

Bove R, White CC, Fitzgerald KC, Chitnis T, Chibnik L, Ascherio A, Munger KL.

Neurology. 2016 Oct 4;87(14):1457-1463. Epub 2016 Sep 7.

14.

Epidemiology of Major Neurodegenerative Diseases in Women: Contribution of the Nurses' Health Study.

Hagan KA, Munger KL, Ascherio A, Grodstein F.

Am J Public Health. 2016 Sep;106(9):1650-5. doi: 10.2105/AJPH.2016.303324. Epub 2016 Jul 26. Review.

15.

Weighing Evidence from Mendelian Randomization-Early-Life Obesity as a Causal Factor in Multiple Sclerosis?

Ascherio A, Munger KL.

PLoS Med. 2016 Jun 28;13(6):e1002054. doi: 10.1371/journal.pmed.1002054. eCollection 2016 Jun.

16.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Sena A, Capela C, Ferret-Sena V, Munger KL, Ascherio A, Suarez G.

Neurology. 2016 May 24;86(21):2026. doi: 10.1212/01.wnl.0000484266.87397.05. No abstract available.

PMID:
27217468
17.

Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention-An Update.

Ascherio A, Munger KL.

Semin Neurol. 2016 Apr;36(2):103-14. doi: 10.1055/s-0036-1579693. Epub 2016 Apr 26. Review.

PMID:
27116717
18.

Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort.

Munger KL, Åivo J, Hongell K, Soilu-Hänninen M, Surcel HM, Ascherio A.

JAMA Neurol. 2016 May 1;73(5):515-9. doi: 10.1001/jamaneurol.2015.4800.

19.

Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.

Fitzgerald KC, Munger KL, Köchert K, Arnason BG, Comi G, Cook S, Goodin DS, Filippi M, Hartung HP, Jeffery DR, O'Connor P, Suarez G, Sandbrink R, Kappos L, Pohl C, Ascherio A.

JAMA Neurol. 2015 Dec;72(12):1458-65. doi: 10.1001/jamaneurol.2015.2742.

PMID:
26458124
20.

No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT.

Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalbán X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A.

Neurology. 2015 Nov 10;85(19):1694-701. doi: 10.1212/WNL.0000000000002099. Epub 2015 Oct 9.

Supplemental Content

Loading ...
Support Center